Z-1261-2023Class II
TEMA Axle Small, REF 1590.15.010 (additional information is pending receipt of the firm's product...
Limacorporate S.p.A. / initiated 2023-01-25 / Open, Classified / root cause: manufacturing process
Limacorporate S.p.A began a recall of TEMA Axle Small, REF 1590.15.010 (additional information is pending receipt of the firm's product label/labeling) on . FDA classified it as Class II and gives the reason as "Due to the incorrect component, that is not cleared to be marketed in the U.S., being included in its elbow prosthesis". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.
Recall record
- Recall number
- Z-1261-2023
- Classification
- Class II
- Status
- Open, Classified
- Initiated
- Posted
- Recalling firm
- Limacorporate S.p.A.
- Product
- TEMA Axle Small, REF 1590.15.010 (additional information is pending receipt of the firm's product label/labeling)
- Product code
- JDC Prosthesis, Elbow, Constrained, Cemented
- Reason for recall
- Due to the incorrect component, that is not cleared to be marketed in the U.S., being included in its elbow prosthesis.
- Root cause tag
- manufacturing process
- FDA root cause
- Employee error
- Action
- On or about 01/25/2023, the firm sent a "VOLUNTARY CORRECTION" Letter via email to customers informing them that the firm has become aware that it incorrectly included low constraint Tema axle small components (not cleared for marketing in U.S.) with its high constraint humeral bodies system. According to the firm's records, 3 low constraint components were implanted between 12/10/2021 to 07/05/2022. Customers are being instructed to: LimaCorporate suggests to Surgeons and Hospitals where an affected device listed in Table 1 was implanted in combination with high constraint humeral bodies components belonging to the product family 1550.15.0XX to yearly follow-up patients with radiographs and varus/valgus range-of-motion evaluation to assess for poly bushing wear. If the follow-up monitoring after 24 months from the implant date shows uneventful and no abnormality, surgeons are invited to do patient follow-up according to the standard protocols, except in case of pain subsequently experienced by the patient. In addition, customers will be instructed by the firm's U.S Regulatory Affairs Associate to post the letter in or near implanted patients' records to continuously remind surgeons and hospitals to monitor their implant patients regarding this Voluntary Correction. For questions or further assistance, contact the firm via email at [email protected].
- Quantity in commerce
- 5 systems
- Distribution
- U.S. Distribution to: TX
- Product codes and lots
- Product Code: 1590.15.010 UDI-DI Code: 08033390128865 Lot Number: 2115522 Sterilization Lot Number: 2100241
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-1261-2023 | Class II | Ongoing | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
